|
| ID |
DDInter973 |
| Drug Type |
small molecule |
| Molecular Formula |
C33H38N4O6 |
| Molecular Weight |
586.689
|
| Description |
Irinotecan is an antineoplastic enzyme inhibitor used to treat metastatic carcinoma of the colon or rectum.
|
| ATC Classification |
L01XX19
|
| IUPAC Name |
(19S)-10,19-Diethyl-19-Hydroxy-14,18-Dioxo-17-Oxa-3,13-Diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]Henicosa-1(21),2,4(9),5 |
| InChI |
Inchi=1S/C33H38N4O6/C1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/H8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/T33-/M0/S1 |
| InChI Key |
UWKQSNNFCGGAFS-XIFFEERXSA-N |
| Canonical SMILES |
CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|